ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2013

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).

Adam L Boxer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.